| 000 | 01859 a2200517 4500 | ||
|---|---|---|---|
| 005 | 20250518010505.0 | ||
| 264 | 0 | _c20191125 | |
| 008 | 201911s 0 0 eng d | ||
| 022 | _a1538-8514 | ||
| 024 | 7 |
_a10.1158/1535-7163.MCT-18-0141 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aKhan, Mohammad Imran | |
| 245 | 0 | 0 |
_aAKT Inhibition Modulates H3K4 Demethylase Levels in PTEN-Null Prostate Cancer. _h[electronic resource] |
| 260 |
_bMolecular cancer therapeutics _c02 2019 |
||
| 300 |
_a356-363 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article; Research Support, N.I.H., Extramural | ||
| 650 | 0 | 4 |
_aAcetylation _xdrug effects |
| 650 | 0 | 4 | _aAnimals |
| 650 | 0 | 4 | _aCell Line, Tumor |
| 650 | 0 | 4 |
_aGene Expression Regulation, Neoplastic _xdrug effects |
| 650 | 0 | 4 | _aGene Knockout Techniques |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 |
_aJumonji Domain-Containing Histone Demethylases _xgenetics |
| 650 | 0 | 4 | _aMale |
| 650 | 0 | 4 |
_aMethylation _xdrug effects |
| 650 | 0 | 4 | _aMice |
| 650 | 0 | 4 |
_aMicroRNAs _xgenetics |
| 650 | 0 | 4 |
_aNuclear Proteins _xgenetics |
| 650 | 0 | 4 |
_aPTEN Phosphohydrolase _xgenetics |
| 650 | 0 | 4 |
_aPhosphorylcholine _xadministration & dosage |
| 650 | 0 | 4 |
_aProstatic Neoplasms _xdrug therapy |
| 650 | 0 | 4 |
_aProto-Oncogene Proteins c-akt _xantagonists & inhibitors |
| 650 | 0 | 4 |
_aRepressor Proteins _xgenetics |
| 650 | 0 | 4 | _aXenograft Model Antitumor Assays |
| 700 | 1 | _aHamid, Abid | |
| 700 | 1 | _aRath, Suvasmita | |
| 700 | 1 | _aAteeq, Bushra | |
| 700 | 1 | _aKhan, Qateeb | |
| 700 | 1 | _aSiddiqui, Imtiaz A | |
| 700 | 1 | _aAdhami, Vaqar Mustafa | |
| 700 | 1 | _aChoudhry, Hani | |
| 700 | 1 | _aZamzami, Mazin A | |
| 700 | 1 | _aMukhtar, Hasan | |
| 773 | 0 |
_tMolecular cancer therapeutics _gvol. 18 _gno. 2 _gp. 356-363 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1158/1535-7163.MCT-18-0141 _zAvailable from publisher's website |
| 999 |
_c29061770 _d29061770 |
||